Cryopyrin-associated periodic syndrome (CAPS)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Synonyms and keywords:
Overview
Cryopyrin-associated periodic syndrome (CAPS) is a rare disease entity encompassing three different clinical phenotypes including Muckle-Wells syndrome (MWS), neonatal-onset multisystem inflammatory disorder (NOMID), and familial cold autoinflammatory syndrome (FCAS). The three aforementioned phenotypes occur due to a common gene mutation.
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating ((Page name)) from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
There are no ECG findings associated with cryopyrin-associated periodic syndrome.
X-ray
- There are no x-ray findings associated with cryopyrin-associated periodic syndrome.
Echocardiography or Ultrasound
- There are no echocardiography/ultrasound findings associated with cryopyrin-associated periodic syndrome.
CT scan
- There are no CT scan findings associated with cryopyrin-associated periodic syndrome.
MRI
- There are no MRI findings associated with cryopyrin-associated periodic syndrome.
Other Imaging Findings
- There are no other imaging findings associated with cryopyrin-associated periodic syndrome.
Other Diagnostic Studies
- There are no other diagnostic studies associated with cryopyrin-associated periodic syndrome.
Treatment
Medical Therapy
- There is no treatment for cryopyrin-associated periodic syndrome; the mainstay of therapy is supportive care.
Surgery
- Surgical intervention is not recommended for the management of cryopyrin-associated periodic syndrome.
Primary Prevention
- There are no established measures for the primary prevention of cryopyrin-associated periodic syndrome.
Secondary Prevention
- There are no established measures for the secondary prevention of cryopyrin-associated periodic syndrome.